date:Feb 27, 2014
ending upon people to do the jobs they were hired to do to provide expert independent opinions, says Itzkoff.
In 2010, the U.S. Government Accountability Office (GAO) issued a report on the GRAS process. In addition to conflict-of-interest issues, the report noted several shortcomings of GRAS and suggested FDA update the process. Since the GAO report, FDA has reopened comments on the 1997 proposed rule, which outlines the GRAS program currently used by manufacturers.
But FDA is not likely to